Delivery Order SPE2DB22D3004-SPE2DB25FPV11
Award Date
3/7/25
Potential Completion Date
3/10/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is an order placed under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,498.20, is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical pharmaceutical product. The contract has a February 2024 completion date and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,050.18, is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with a value of $1,726.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has a period of performance through June 25, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating the contract was competed openly....
This federal contract award, valued at $15,004.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 240 MG/ML, a medical product, with an ultimate completion date of April 21, 2023. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,307.00 Firm Fixed Price Delivery Order is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a critical medical commodity. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a medical product, with a ceiling value of $1,147.37 and a performance period through May 15, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,513.00 firm fixed-price delivery order covers the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a specialty pharmaceutical product. The contract has a completion date of June 27, 2023 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,322.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,984.20 firm fixed-price delivery order is for the supply of Omnipaque 350 mg/ml infusion bottles, a radiopaque contrast agent used in medical imaging procedures. The contract has a completion date of July 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FN2Z2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,653.50 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has an ultimate completion date of April 5, 2024. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...